Encapsulation of bovine serum albumin in poly(lactide-co-glycolide) microspheres by the solid-in-oil-in-water technique

被引:75
作者
Castellanos, IJ [1 ]
Carrasquillo, KG [1 ]
López, JD [1 ]
Alvarez, M [1 ]
Griebenow, K [1 ]
机构
[1] Univ Puerto Rico, Dept Chem, San Juan, PR 00931 USA
关键词
D O I
10.1211/0022357011775361
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Non-aqueous protocols to encapsulate pharmaceutical proteins into biocompatible polymers have gained much attention because they allow for the minimization of procedure-induced protein structural perturbations. The aim of this study was to determine if these advantages could be extended to a semi-aqueous encapsulation procedure, namely the solid-in-oil-in-water (s/o/w) technique. The model protein bovine serum albumin (BSA) was encapsulated into poly(lactide-co-glycolide) (PLG) microspheres by first suspending lyophilized BSA in methylene chloride containing PLG, followed by emulsification in a 1% aqueous solution of poly(vinyl alcohol). By variation of critical encapsulation parameters (homogenization intensity, BSA:PLG ratio, emulsifier concentration, ratio of organic to aqueous phase) an encapsulation efficiency of > 90 % was achieved. The microspheres obtained showed an initial burst release of < 20 %, a sustained release over a period of about 19 days, and a cumulative release of at least 90 % of the encapsulated BSA. Different release profiles were observed when using different encapsulation protocols. These differences were related to differences in the microsphere erosion observed using scanning electron microscopy. Release of BSA was mainly due to simple diffusion or to both diffusion and microsphere erosion. Fourier-transform infrared studies were conducted to investigate the secondary structure of BSA during the encapsulation. Quantification of the <alpha>-helix and beta -sheet content as well as of overall structural changes showed that the secondary structure of encapsulated BSA was not more perturbed than in the lyophilized powder used initially. Thus, the encapsulation procedure did not cause detrimental structural perturbations in BSA. in summary, the results demonstrate that the s/o/w technique is an excellent alternative to the water-in-oil-in-water technique, which is still mainly used in the encapsulation of proteins in PLG microspheres.
引用
收藏
页码:167 / 178
页数:12
相关论文
共 31 条
[1]   BIODEGRADABLE MICROSPHERES AS CONTROLLED-RELEASE TETANUS TOXOID DELIVERY SYSTEMS [J].
ALONSO, MJ ;
GUPTA, RK ;
MIN, C ;
SIBER, GR ;
LANGER, R .
VACCINE, 1994, 12 (04) :299-306
[2]   Fabrication of microspheres using blends of poly(ethylene adipate) and poly(ethylene adipate)/poly(hydroxybutyrate-hydroxyvalerate) with poly(caprolactone): Incorporation and release of bovine serum albumin [J].
Atkins, TW .
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, 1997, 8 (11) :833-845
[3]   The incorporation and release of bovine serum albumin from poly-hydroxybutyrate-hydroxyvalerate microcapsules [J].
Atkins, TW ;
Peacock, SJ .
JOURNAL OF MICROENCAPSULATION, 1996, 13 (06) :709-717
[4]   A theoretical model of erosion and macromolecular drug release from biodegrading microspheres [J].
Batycky, RP ;
Hanes, J ;
Langer, R ;
Edwards, DA .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (12) :1464-1477
[5]  
Carrasquillo Karen G., 1998, Pharmacy and Pharmacology Communications, V4, P563
[6]   Relationship between conformational stability and lyophilization-induced structural changes in chymotrypsin [J].
Carrasquillo, KG ;
Sanchez, C ;
Griebenow, K .
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2000, 31 (31) :41-53
[7]   On the structural preservation of recombinant human growth hormone in a dried film of a synthetic biodegradable polymer [J].
Carrasquillo, KG ;
Costantino, HR ;
Cordero, RA ;
Hsu, CC ;
Griebenow, K .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 88 (02) :166-173
[8]   Reduction of structural perturbations in bovine serum albumin by non-aqueous microencapsulation [J].
Carrasquillo, KG ;
Carro, JCA ;
Alejandro, A ;
Toro, DD ;
Griebenow, K .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2001, 53 (01) :115-120
[9]   Characterization of PLGA microspheres for the controlled delivery of IL-1 alpha for tumor immunotherapy [J].
Chen, L ;
Apte, RN ;
Cohen, S .
JOURNAL OF CONTROLLED RELEASE, 1997, 43 (2-3) :261-272
[10]   Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres [J].
Cleland, JL ;
Jones, AJS .
PHARMACEUTICAL RESEARCH, 1996, 13 (10) :1464-1475